Dépistage de l’hypertension artérielle pulmonaire au cours de la sclérodermie systémique : étude d’une cohorte de 67 patients

Battle, 1996, Prevalence of pulmonary hypertension in limited and diffuse scleroderma, Chest, 110, 1515, 10.1378/chest.110.6.1515

Koh, 1996, Pulmonary hypertension in systemic sclerosis : an analysis of 17 patients, Br J Rheumatol, 35, 989, 10.1093/rheumatology/35.10.989

Altman, 1991, Predictors of survival in systemic sclerosis (scleroderma), Arthritis Rheum, 34, 403, 10.1002/art.1780340405

Parent-Woillez, 1997, L'hypertension artérielle pulmonaire primitive : une complication rare mais souvent mortelle du Crest syndrome, Rev Méd Interne, 18, 109, 10.1016/S0248-8663(97)84675-9

Stupi, 1986, Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis, Arthritis Rheum, 29, 515, 10.1002/art.1780290409

Wanstall, 1998, Recognition and management of pulmonary hypertension, Drugs, 56, 989, 10.2165/00003495-199856060-00004

Olschewski, 1996, Aerosolized prostacyclin and iloprost in severe pulmonary hypertension, Ann Intern M, 124, 820, 10.7326/0003-4819-124-9-199605010-00006

Masi, 1980, Medsger TA, and Subcommittee For Scleroderma Criteria of The American Rheumatism Association Diagnostic and Therapeutic Criteria Committee : preliminary criteria for the classification of systemic sclerosis (scleroderma), Arthritis Rheum, 23, 581, 10.1002/art.1780230510

LeRoy, 1988, Scleroderma (systemic sclerosis) : classification, subsets and pathogenesis, J Rheumatol, 15, 202

Harris, 1990, The second international anticardiolipin standardization workshop / The kingstone antiphospholipid antibody study group, Am J Clin Pathol, 94, 476, 10.1093/ajcp/94.4.476

Rémy-Jardin, 1993, Pulmonary involvement in progressive systemic sclerosis : sequential evaluation with CT, pulmonary function tests and bronchoalveolar lavage, Radiology, 188, 499, 10.1148/radiology.188.2.8327704

Quanjer, 1993, Standardization of the measurements of transfer factor (diffusing capacity). Report working party standardization of lung function tests, European Community for Steel and Coal. Official statement of the European Society, Eur Respir J, 16, 5, 10.1183/09041950.005s1693

Currie, 1985, Continuous-wave Doppler determination of right ventricular pressure : a simultaneous Doppler-catheterization study in 127 patients, J Am Coll Cardiol, 6, 750, 10.1016/S0735-1097(85)80477-0

Hatle, 1978, Noninvasive assessment of pressure drop in mitral stenosis by Doppler ultrasound, Br Heart J, 40, 131, 10.1136/hrt.40.2.131

Yousem, 1990, The pulmonary pathologic manifestations of the CREST syndrome, Hum Pathol, 21, 467, 10.1016/0046-8177(90)90002-M

Ungerer, 1983, Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis, Am J M, 75, 65, 10.1016/0002-9343(83)91169-5

Bolster, 1993, Lung disease in systemic sclerosis (scleroderma), Clin Rheumatol, 7, 79

Yock, 1984, Non invasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation, Circulation, 70, 657, 10.1161/01.CIR.70.4.657

Denton, 1997, Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis, Br J Rheumatol, 36, 239, 10.1093/rheumatology/36.2.239

Battle, 1994, Doppler estimation of pulmonary artery pressures revisited, Echocardiography, 11, 455, 10.1111/j.1540-8175.1994.tb01085.x

Trell, 1971, Pulmonary hypertension in systemic sclerosis, Ann Rheum Dis, 30, 390, 10.1136/ard.30.4.390

Salerni, 1977, Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma), Ann Intern M, 86, 394, 10.7326/0003-4819-86-4-394

D'Angelo, 1969, Pathologic observations in systemic sclerosis, Am J M, 46, 428, 10.1016/0002-9343(69)90044-8

Palevsky, 1989, Primary pulmonary hypertension. Vascular structure, morphometry, and responsiveness to vasodilator agents, Circulation, 80, 1207, 10.1161/01.CIR.80.5.1207

Steen, 1985, Pulmonary involvement in systemic sclerosis (scleroderma), Arthritis Rheum, 28, 759, 10.1002/art.1780280706

Karmochkine, 1996, High prevalence of antiphospholipid antibodies in precapillary pulmonary hypertension, J Rheumatol, 23, 286

Del Papa, 1992, Relationship between anti-phospholipid and anti-endothelial cell antibodies : further characterization of the reactivity on resting and cytokine-activated endothelial cells, Clin Exp Rheumatol, 10, 37

Owens, 1987, Cardiopulmonary manifestations of systemic sclerosis, Chest, 91, 118, 10.1378/chest.91.1.118

Steen, 1992, Isolated diffusing capacity reduction in systemic sclerosis, Arthritis Rheum, 35, 765, 10.1002/art.1780350709

Marie, 1999, Atteinte pulmonaire au cours de la sclérodermie systémique. Partie I. Pneumopathie interstitielle chronique fibrosante, Rev Méd Interne, 20, 1004, 10.1016/S0248-8663(00)87081-2